| 000 | 01867 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250513230731.0 | ||
| 264 | 0 | _c20010823 | |
| 008 | 200108s 0 0 eng d | ||
| 022 | _a1198-743X | ||
| 024 | 7 |
_a10.1046/j.1469-0691.2000.00008.x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aHarthug, S | |
| 245 | 0 | 0 |
_aVancomycin resistance emerging in a clonal outbreak caused by ampicillin-resistant Enterococcus faecium. _h[electronic resource] |
| 260 |
_bClinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases _cJan 2000 |
||
| 300 |
_a19-28 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAmpicillin _xpharmacology |
| 650 | 0 | 4 | _aAmpicillin Resistance |
| 650 | 0 | 4 |
_aAnti-Bacterial Agents _xpharmacology |
| 650 | 0 | 4 |
_aCross Infection _xdrug therapy |
| 650 | 0 | 4 | _aDisease Outbreaks |
| 650 | 0 | 4 | _aElectrophoresis, Gel, Pulsed-Field |
| 650 | 0 | 4 |
_aEnterococcus faecium _xdrug effects |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aGenotype |
| 650 | 0 | 4 |
_aGram-Positive Bacterial Infections _xdrug therapy |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aIncidence |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMicrobial Sensitivity Tests |
| 650 | 0 | 4 |
_aNorway _xepidemiology |
| 650 | 0 | 4 |
_aPenicillins _xpharmacology |
| 650 | 0 | 4 |
_aVancomycin _xpharmacology |
| 650 | 0 | 4 | _aVancomycin Resistance |
| 700 | 1 | _aDigranes, A | |
| 700 | 1 | _aHope, O | |
| 700 | 1 | _aKristiansen, B E | |
| 700 | 1 | _aAllum, A G | |
| 700 | 1 | _aLangeland, N | |
| 773 | 0 |
_tClinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases _gvol. 6 _gno. 1 _gp. 19-28 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1046/j.1469-0691.2000.00008.x _zAvailable from publisher's website |
| 999 |
_c11107021 _d11107021 |
||